The Food Safety and Standards Act, 2006 (FSS Act) marked a significant overhaul of India’s food regulatory landscape, bringing together many outdated and overla ...

The Karnataka government declared 14 drugs manufactured by different companies “substandard” on 25 June 2025, and warned ...

Wegovy is only approved for obesity in India. Novo Nordisk has no immediate plans to launch Ozempic for type 2 diabetes, ...

The FDA's approval of lenacapavir, a highly effective HIV prevention drug, sparks debate in India due to its high cost of ₹24 ...

Bengaluru: The Karnataka government’s Drug Testing Laboratory declared 14 drugs manufactured by 14 different companies as ...

KA Gov Flags 14 Drugs As Sub-Standard directs chemists, wholesalers, doctors, hospitals, and nursing homes not to stock, sell ...

Oprah Winfrey and Elon Musk endorsed it. And though Indian celebrities haven’t yet admitted to their use, the mystery ...

Zepto has been stirring controversy over allegations of food safety violations and mistreatment of delivery partners.

Danish drugmaker Novo Nordisk has launched its popular weight-loss drug Wegovy in India, months after its rival Mounjaro’s ...

ProPublica spent 14 months investigating the FDA’s oversight of foreign drugmakers that send medications to the U.S. These ...

A spate of mid-flight illnesses on a recent Air India London–Mumbai service has cast a harsh light on airline catering ...

Wegovy, a weekly weight-loss injection by Novo Nordisk, has launched in India. Priced from Rs 17,000/month, it helps users lose up to 20 per cent body weight. But is it safe? Experts answer.